MedPath
NMPA Approval

Hydroxycarbamide Tablets

国药准字H45020227

August 13, 2020

国药准字H45020227

Drug Information

羟基脲片

百会

片剂

0.5g

化学药品

August 13, 2020

Company Information

Applicant Company

广西南宁市金阳路39号

Manufacturing Company

广西南宁市金阳路39号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羟基脲片 - NMPA 批准文号 | MedPath